Skip to content
Metabolic peptides

AOD-9604

AOD-9604 is a synthetic analogue of the lipolytic C-terminal region of human growth hormone, studied in rodent models. Approved buyers can apply for access.

US Peptide Distributors supplies AOD-9604 at wholesale to approved business buyers in 5mg and 10mg vials, from USA stock with same-day shipping and overseas-sourced supply (typically 7-10 days). Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. There is no minimum order on USA stock. Pricing is quoted by supply option and tiered by volume.

Updated

Synonyms
AOD9604
Formula
C78H123N23O23S2
Molecular weight
1815.1 g/mol
Vial sizes5mg10mg

Approved buyers see pricing

Wholesale pricing is available to approved business buyers after they log in.

Supply and testing

  • Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
  • Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
  • Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
  • No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
  • COA in your company nameCan be added to an order and is provided with it.

Distributor programShipping times

Request a quote for AOD-9604

A fragment, not the hormone

AOD-9604 is easy to misread as a growth hormone product. It is not. It is a synthetic analogue of the lipolytic domain at the C-terminus of human growth hormone, made as a 1,815 g/mol peptide that does not include the rest of the protein. The rat study below compares it directly with intact growth hormone, including on insulin sensitivity, which is the contrast that made the fragment interesting.

Evidence in obese rodents

Two animal studies carry most of the weight.

Obese mice. In the 2001 Endocrinology paper, human growth hormone and AOD9604 were each given to obese mice for 14 days, and the authors reported lower body mass and body fat in both treated groups. Both raised the level of beta-3 adrenergic receptor RNA, which is the main lipolytic receptor in fat cells and was repressed in the obese animals, back toward the level seen in lean mice. The experiment's key control used beta-3 receptor knock-out mice, in which long-term treatment did not produce the changes in body mass and lipolysis seen in wild-type mice. That result points to the beta-3 pathway as necessary for the effect.

Obese Zucker rats. The earlier 2000 study in Zucker rats reported that, over 19 days of daily treatment, body mass gain was 15.8 grams in the treated rats and 35.6 grams in controls, and that lipolytic activity in adipose tissue was higher in the treated rats. Unlike chronic intact growth hormone, it showed no adverse effect on insulin sensitivity in euglycemic clamp experiments.

Clinical development

A short industry profile in Current Opinion in Investigational Drugs notes that the compound was under development, and that phase IIa trials were under way by February 2002. We mention this only to show the compound has a clinical-development history; the profile does not report outcomes.

Documentation and fulfilment

Because AOD-9604 is a mid-sized peptide with two sulfur atoms in its formula, the main analytical questions are the mass match and the impurity profile. If you buy in volume and ship to your own customers, our guide on choosing a peptide fulfillment partner covers what to ask before you commit.

Supply is for approved business buyers, for laboratory research use only.

References

  1. Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001.
  2. Ng FM, et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000.
  3. Wilding J. AOD-9604 Metabolic. Curr Opin Investig Drugs. 2004.

Questions

Where can I buy AOD-9604 in bulk?

US Peptide Distributors supplies AOD-9604 to approved business buyers in 5mg and 10mg vials, from USA stock with same-day shipping and overseas-sourced supply (typically 7-10 days). Apply for a buyer account to see wholesale pricing; larger volumes are quoted on request.

How much does AOD-9604 cost wholesale?

US Peptide Distributors shows wholesale pricing for AOD-9604 to approved business accounts after login. Pricing is quoted by supply option and tiered by volume, so the per-box price falls as the box count rises.

Is AOD-9604 sold for use in humans?

No. US Peptide Distributors sells AOD-9604 to approved business buyers for laboratory research use only, not for use in humans.

Can I buy AOD-9604 from a US supplier?

Yes. US Peptide Distributors holds AOD-9604 in USA stock, which ships from US inventory with same-day shipping and expedited options available. There is no minimum order on USA stock.

Is each lot of AOD-9604 third-party tested?

Yes. Every lot US Peptide Distributors supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.